Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pegylated liposomal doxorubicin
Sponsor: Herlev Hospital
Collaborators: Rigshospitalet, Denmark|Odense University Hospital|Aarhus University Hospital